The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial

Overview of attention for article published in Trials, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog

policy: 1 policy source
twitter: 45 X users

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 238 Mendeley

Summary News Blogs Policy documents X Dimensions citations

So far, Altmetric has seen 72 X posts from 45 X users, with an upper bound of 218,560 followers.

@William02101980 @caiomrb https://t.co/nM27zBejnQ

Reply Repost Favourite

軽度・中等度のCovid患者におけるイベル●クチンの有効性および安全性に関する無作為化比較対照試験＠イラン…というのもある。必ずしも的外れ…ではないことだけは頭に入れて謙虚でありたい…(推すわけではない😂) https://t.co/3VtHMXZEf6

Reply Repost Favourite

@Lindor976 @Tythan31 @PhilippeMurer Je suis Dr en épidémio, Mr "Ad personam"... Pas un prix Nobel, juste bien renseigné vu que bossant directement sur le covid. Et en fait, ça se sait pour l'IVM: 1 https://t.co/0CI1qErRDQ 2 https://t.co/TwZCSsugpv 3 https:

Reply Repost Favourite

@DariusLowber @Cactusrose5 @TimRunsHisMouth https://t.co/aswi78jRcw

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 68 additional X posts.